Study of Standard Intensive Chemotherapy Versus Intensive Chemotherapy With CPX-351 in Adult Patients With Newly Diagnosed AML and Intermediate- or Adverse Genetics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Cytarabine
Related studies linked through entity extraction aliases.
Isatuximab in Combination With Chemotherapy in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
A Study Evaluating the Safety and Efficacy of Idasanutlin in Combination With Cytarabine and Daunorubicin in Patients Newly Diagnosed With Acute Myeloid Leukemia (AML) and the Safety and Efficacy of Idasanutlin in the Maintenance of First AML Complete Remission
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
DLCL002 Protocol for Patients With High Risk Aggressive B-cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Pevonedistat, Azacitidine, Fludarabine Phosphate, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1
Low-Intensity Chemotherapy and Venetoclax in Treating Patients With Relapsed or Refractory B- or T-Cell Acute Lymphoblastic Leukemia
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Safety and Efficacy of Quizartinib in Children and Young Adults With Acute Myeloid Leukemia (AML), a Cancer of the Blood
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Palbociclib in Combination With Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LL)
- Status
- COMPLETED
- Phase
- PHASE1
Dexamethasone in Refractory or First Relapsed Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE3
HDM201 Added to CT in R/R or Newly Diagnosed AML
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Acalabrutinib Plus RICE for Relapsed/Refractory DLBCL
- Status
- UNKNOWN
- Phase
- PHASE2
Prexasertib in Combination With MEC in Relapsed/Refractory AML and High Risk MDS - a Phase I Trial
- Status
- TERMINATED
- Phase
- PHASE1
Pinometostat With Standard Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia and MLL Gene Rearrangement
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Early Systemic Central Nervous System Prophylaxis in Diffuse Large B-cell Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Ibrutinib, Rituximab, Venetoclax, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Venetoclax in Combination With Intensive Induction and Consolidation Chemotherapy in Treatment Naïve AML
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Selinexor (KPT-330) Plus FLAG-Ida for the Treatment of Relapsing/Refractory AML
- Status
- COMPLETED
- Phase
- PHASE1
Phase 1 Study of the Dual MDM2/MDMX Inhibitor ALRN-6924 in Pediatric Cancer
- Status
- COMPLETED
- Phase
- PHASE1